01:19 , Oct 6, 2018 |  BioCentury  |  Finance

In sight of uncharted territory

Strong growth from small- and mid-caps coupled with a late run from large cap biotechs has pushed the sector within sight of its all-time high in 2015. Some buysiders now are seeing red flags of...
12:05 , May 3, 2018 |  BioCentury  |  Finance

Foresite into data

With a new $668 million fund, Foresite Capital is positioning itself to invest in more healthcare companies that use data science and machine learning in drug discovery and development, diagnostics, and patient identification and monitoring....
19:58 , Apr 27, 2018 |  BC Week In Review  |  Financial News

10x Genomics raises $125M in series D, credit facility

10x Genomics Inc. (Pleasanton, Calif.) raised $50 million on April 26 in an untranched series D round led by new investor Meritech Capital Partners. New investor Wells Fargo Strategic Capital also participated, as did existing...
18:36 , Apr 26, 2018 |  BC Extra  |  Financial News

10x Genomics raises $125M in series D, credit facility

10x Genomics Inc. (Pleasanton, Calif.) raised $50 million in an untranched series D round led by new investor Meritech Capital Partners. New investor Wells Fargo Strategic Capital also participated, as did existing investors Paladin Capital,...
21:12 , Mar 2, 2018 |  BioCentury  |  Finance

Genome toolbox

The syndicate behind Inscripta Inc.’s $55.5 million series C round includes investors well-versed in genome reading and writing that are making a foray into genome editing. New investor Mérieux Développement and existing investor Paladin Capital...
00:38 , Mar 23, 2017 |  BC Innovations  |  Distillery Techniques

Assays and screens; drug platforms

TECHNOLOGY: Cellular assays; peptides A genomic and proteomic screening method could identify neoantigens as personalized immunotherapy targets for cancer. The method involved collecting tumor and non-tumor tissue samples from a patient; immunoprecipitating human leukocyte antigen...
07:00 , Oct 24, 2016 |  BC Week In Review  |  Company News

10x Genomics sales and marketing update

10x launched the Chromium Single Cell Controller for single-cell analytics in the U.S. for $50,000. The company did not respond to inquiries. 10x Genomics Inc. , Pleasanton, Calif.  Business: Genomics ...
07:00 , May 30, 2016 |  BC Week In Review  |  Company News

10x Genomics sales and marketing update

10x launched the Chromium System for whole genome or exome sequencing and single-cell analytics. The system runs on the GemCode platform. 10x Genomics Inc. , Pleasanton, Calif.   Business: Genomics  ...
07:00 , Apr 11, 2016 |  BioCentury  |  Tools & Techniques

Stepping on the scale

By giving other companies' short-read sequencers the ability to perform long reads, 10x Genomics Inc. expects researchers will be able to fully unlock the genome. Co-founders CEO Serge Saxonov, COO and CTO Kevin Ness and...
07:00 , Mar 21, 2016 |  BC Week In Review  |  Financial News

10x Genomics completes venture financing

10x Genomics Inc. , Pleasanton, Calif.   Business: Genomics, Supply/Service   Date completed: 2016-03-17   Type: Venture financing   Raised: $55 million   Investors: Fidelity; Softbank; JS Capital Management; Venrock; Foresite Capital Management; Paladin Capital...